NCT02312089 is a Phase 4 clinical trial of Triptorelin in Infertility, sponsored by Mansoura University.

Who is sponsoring NCT02312089?

NCT02312089 is sponsored by Mansoura University.

What drugs are being tested in NCT02312089?

Interventions in NCT02312089: Triptorelin.

What condition does NCT02312089 study?

NCT02312089 studies Infertility.

Is NCT02312089 still recruiting?

NCT02312089 is currently status unknown. Last updated 30 October 2023.

Last reviewed 2023-10-30 · How we verify

NCT02312089

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles

Status unknown Phase 4 Last updated 30 October 2023

What this trial tests

Phase 4 trial testing Triptorelin in Infertility in 200 participants. Status unknown.

Timeline

7 August 2016

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Mansoura University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	200
Start date	7 August 2016
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	2 locations across Egypt

Drugs / interventions tested

Triptorelin (triptorelin) — full drug profile →

Conditions studied

Infertility — all drugs for Infertility →

Sponsor

Mansoura University

Who can join

Adults 20 to 38, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the effect of adding a single dose of gonadotropin releasing hormone agonist (GnRHa) as a luteal phase support on the outcomes of intracytoplasmic sperm injection (ICSI) following GnRH antagonist protocol

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Luteal phase support for assisted reproduction cycles.
van der Linden M, Buckingham K, Farquhar C, Kremer JA, et al · · 2015 · cited 170× · PMID 26148507 · DOI 10.1002/14651858.cd009154.pub3

Verify or expand the search:

Other trials of Triptorelin

Trials testing the same drug.

NCT06378866 — Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivati · Phase 2 · recruiting
NCT05896566 — A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients Wi · Phase 2 · completed
NCT06581679 — Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer · NA · completed
NCT05972902 — Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes · Phase 3 · unknown
NCT05050084 — Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients · Phase 3 · active not recruiting

Other recruiting trials for Infertility

Currently open trials in the same condition.

NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02312089 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 30 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02312089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing